Did GOOGL's Jul 22 capex-guidance selloff break it from fellow hyperscalers?
Treated: GOOGL. Donors: MSFT, META, AMZN (fellow Mag-7 hyperscalers, all running their own large AI-capex programs and facing similar market scrutiny over it). Hand-picked, not algorithmic. Treatment date is GOOGL's Jul 22 after-close report: Cloud grew 63% YoY, a strong number, but $190B capex guidance crushed the FCF margin (21%→10, from 21%→9.2% per prior notes) and the stock sold off anyway. Tests whether this was a GOOGL-specific reaction to its own guidance, or part of a shared 'market re-pricing hyperscaler AI-capex risk' move that should also show up in the donor pool.
Actual vs. synthetic counterfactual
ActualSynthetic (counterfactual)
Fit quality
Fit-window RMSE4.5817
RMSE ÷ fit-window std dev0.46×
Fit-window days125
Confound-window mean gapn/a (fit-end = treatment date)
Post-period mean gap-5.47
Placebo test: same method run on every unit, treated one highlighted
Unit
Mean post-period gap
Max abs. gap
META
-12.72%
23.54%
MSFT
+11.90%
23.41%
GOOGL (treated)
-5.47%
12.04%
AMZN
+5.34%
11.27%
Verdict
GOOGL's post-period gap ranks #3 of 4 units by absolute size in the placebo test (larger rank = more likely a real, unit-specific effect rather than noise the method would produce for any random unit).
Read: this does NOT look like a clearly unit-specific effect; other units in the placebo test show gaps of similar or larger size, so this could just be estimation noise rather than a real, distinct move.